Project description
Advancing contrast agents for MRI scans
Magnetic resonance imaging (MRI) scans produce detailed images of the organs and tissues in the body. They can also provide new insights into the biology of cell trafficking and migration. It is important to advance MRI contrast agents in order to render MRI a high-resolution and non-invasive preclinical and clinical imaging modality. The EU-funded SENATOR project will form an international and inter-sectoral network of organisations working on a joint research programme to advance contrast agents based on nanoparticles for perfluorocarbon (19F) MRI. The move towards a new generation of MRI contrast agents has been spurred on by the mounting evidence against gadolinium-based contrast agents (GBCAs). Healthcare professionals have been advised to limit the use of GBCAs to situations in which contrast is deemed absolutely necessary.
Field of science
- /natural sciences/chemical sciences/inorganic chemistry/inorganic compounds
- /medical and health sciences/clinical medicine/radiology/medical imaging/magnetic resonance imaging
Call for proposal
H2020-MSCA-RISE-2019
See other projects for this call
Funding Scheme
MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)Coordinator
1649 028 Lisboa
Portugal
Participants (10)
62032 Camerino
80138 Napoli
2333 ZA Leiden
3015 GD Rotterdam
40225 Dusseldorf
2333 BZ Leiden
50931 Koln
84036 Landshut
2171 CD Sassenheim
67659 Kaiserslautern
